Faecal calprotectin in primary care: is its current use supported by the evidence?

被引：0
|
作者：
Perry, Robert W. [1 ,2 ,3 ,5 ]
Mummery, David [4 ]
Alexander, James L. [1 ,2 ,3 ]
Hicks, Lucy C. [1 ,2 ,3 ]
Williams, Horace R. T. [1 ,2 ,3 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Gastroenterol, London, England
[2] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Hepatol, London, England
[3] Imperial Coll London, Fac Med, Dept Metab Digest & Reprod, Div Digest Dis, London, England
[4] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England
[5] Imperial Coll Healthcare NHS Trust, St Marys Hosp, The Bays,South Wharf Rd, London W2 1NY, England
来源：
BRITISH JOURNAL OF GENERAL PRACTICE | 2024年 / 74卷 / 740期
关键词：
INFLAMMATORY-BOWEL-DISEASE; IBD;
D O I：
10.3399/bjgp24X736665
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
[No abstract available]
引用
收藏
页码：134 / 136
页数：3
相关论文
共 50 条
  • [1] Evaluation of a faecal calprotectin care pathway for use in primary care
    Turvill, James
    O'Connell, Shaun
    Brooks, Abigail
    Bradley-Wood, Karen
    Laing, James
    Thiagarajan, Swaminathan
    Hammond, David
    Turnock, Daniel
    Jones, Alison
    Sood, Ruchit
    Ford, Alex
    PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT, 2016, 17 (05): : 428 - 436
  • [2] DIAGNOSTIC PERFORMANCE OF FAECAL CALPROTECTIN IN PRIMARY CARE
    Hunt, N.
    Allcock, R.
    Sharma, A.
    Myers, M.
    GUT, 2014, 63 : A159 - A159
  • [3] CLINICAL VALIDITY AND UTILITY OF FAECAL CALPROTECTIN IN PRIMARY CARE
    Walker, G. J.
    Moore, L.
    Heerasing, N.
    Hendy, P. J.
    Bewshea, C.
    Goodhand, J. R.
    Kennedy, N. A.
    Calvert, C.
    Ahmad, T.
    GUT, 2017, 66 : A252 - A252
  • [4] Faecal calprotectin in primary care to screen for inflammatory bowel disease
    Mellis, Craig
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2021, 57 (03) : 458 - 458
  • [5] USE OF FAECAL CALPROTECTIN IN PRIMARY CARE TO DISTINGUISH IRRITABLE BOWEL SYNDROME FROM INFLAMMATORY BOWEL DISEASE
    Rouke, J. O.
    Dhaliwal, A.
    Sagar, V.
    Davies, J.
    Milestone, A.
    GUT, 2015, 64 : A86 - A87
  • [6] Evaluation of appropriate use of Faecal Calprotectin against current NICE guidance
    Chauhan, V.
    Phillips, J.
    White, T. J.
    Narula, H. S.
    BRITISH JOURNAL OF SURGERY, 2016, 103 : 19 - 19
  • [7] AN EXPLORATORY STUDY OF THE IMPACT OF PRIMARY CARE FAECAL CALPROTECTIN TESTING ON REFERRALS TO SECONDARY CARE
    Taylor, N.
    Everitt, H.
    Latter, S.
    Burrill, K.
    Efrem, E.
    Cummings, F.
    GUT, 2017, 66 : A242 - A242
  • [8] Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms
    Mowat, Craig
    Digby, Jayne
    Strachan, Judith A.
    Wilson, Robyn
    Carey, Francis A.
    Fraser, Callum G.
    Steele, Robert J. C.
    GUT, 2016, 65 (09) : 1463 - 1469
  • [9] Faecal calprotectin is not necessarily required as a screen for significant bowel disease in primary care
    Waite, Matthew Malcolm Andrew
    Langmead, Louise
    Ayling, Ruth M.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2022, 59 (03) : 171 - 177
  • [10] Practical guidance on the use of faecal calprotectin
    Brookes, Matthew J.
    Whitehead, Simon
    Gaya, Daniel R.
    Hawthorne, Antony Barney
    FRONTLINE GASTROENTEROLOGY, 2018, 9 (02) : 87 - 91
12345